Brainsway Ltd. American Depositary Shares (BWAY)

Price$13.89

Value ScoreF

Growth ScoreA

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)66.54%

Price vs S&P 500 (4W)-14.02%

VGM Score60.12

Market Capitalization$1.65B

P/E Ratio (Annual)73.77x

All Metrics

P/CF (Annual)31.95x

Book Value / Share (Quarterly)$1.89

P/TBV (Annual)7.42x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)11.41%

Cash Flow / Share (Quarterly)$0.29

Price vs S&P 500 (YTD)30.31%

Gross Margin (TTM)74.92%

Net Profit Margin (TTM)12.74%

EPS (TTM)$0.23

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$0.23

Revenue Growth (5Y)12.17%

EPS (Annual)$0.19

ROI (Annual)9.47%

Gross Margin (Annual)74.56%

Net Profit Margin (5Y Avg)-20.28%

Cash / Share (Quarterly)$1.49

P/E Basic Excl Extra (TTM)63.78x

Revenue Growth QoQ (YoY)28.66%

P/E Normalized (Annual)73.77x

ROA (Last FY)6.69%

Revenue Growth TTM (YoY)27.08%

EBITD / Share (TTM)$0.19

ROE (5Y Avg)-7.15%

Operating Margin (TTM)5.79%

Cash Flow / Share (Annual)$0.39

P/B Ratio7.37x

P/B Ratio (Quarterly)7.66x

Net Income / Employee (Annual)$58,700

EV / Revenue (TTM)11.52x

Net Interest Coverage (TTM)-42.43x

ROA (TTM)7.70%

EPS Growth QoQ (YoY)197.03%

EV / EBITDA (TTM)76.76x

EPS Incl Extra (Annual)$0.19

Current Ratio (Annual)3.73x

Quick Ratio (Quarterly)3.04x

3-Month Avg Trading Volume0.11M

52-Week Price Return153.31%

EV / Free Cash Flow (Annual)37.33x

P/E Incl Extra (TTM)63.78x

Revenue / Employee (TTM)$380,600

Tangible BV / Share (Quarterly)$0.61

P/S Ratio (Annual)13.62x

Asset Turnover (Annual)0.43x

52-Week High$5123.00

Operating Margin (5Y Avg)-19.52%

EPS Excl Extra (Annual)$0.19

CapEx CAGR (5Y)-1.08%

Tangible BV CAGR (5Y)21.08%

26-Week Price Return74.46%

Quick Ratio (Annual)3.38x

13-Week Price Return11.54%

Total Debt / Equity (Annual)0.09x

Current Ratio (Quarterly)3.34x

Enterprise Value$565.53M

Revenue / Share Growth (5Y)0.93%

Asset Turnover (TTM)0.47x

Book Value / Share Growth (5Y)16.19%

Revenue / Employee (Annual)$318,000

Inventory Turnover (Annual)2.35x

Pretax Margin (Annual)8.43%

Cash / Share (Annual)$1.77

3-Month Return Std Dev51.66%

Gross Margin (5Y Avg)75.40%

Net Income / Employee (TTM)$67,900

EBITDA Interim CAGR (5Y)15.11%

ROE (Last FY)10.35%

Net Interest Coverage (Annual)-3.23x

EPS Basic Excl Extra (Annual)$0.19

P/FCF (TTM)45.80x

Receivables Turnover (TTM)11.35x

EV / Free Cash Flow (TTM)48.84x

Total Debt / Equity (Quarterly)0.09x

EPS Incl Extra (TTM)$0.23

Receivables Turnover (Annual)9.79x

ROI (TTM)11.18%

P/S Ratio (TTM)11.38x

Pretax Margin (5Y Avg)-19.38%

Revenue / Share (Annual)$1.18

Tangible BV / Share (Annual)$0.76

Forward P/E56.13x

Price vs S&P 500 (52W)168.06%

P/E Ratio (TTM)63.78x

EPS Growth TTM (YoY)137.79%

Year-to-Date Return37.28%

5-Day Price Return-0.23%

EPS Normalized (Annual)$0.19

ROA (5Y Avg)-5.22%

Net Profit Margin (Annual)7.12%

Month-to-Date Return-7.74%

Cash Flow / Share (TTM)$-1.31

EBITD / Share (Annual)$0.13

Operating Margin (Annual)3.39%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)40.94x

ROI (5Y Avg)-7.28%

P/E Excl Extra (TTM)63.78x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.23

P/TBV (Quarterly)10.35x

P/B Ratio (Annual)5.52x

Inventory Turnover (TTM)2.34x

Pretax Margin (TTM)14.06%

Book Value / Share (Annual)$1.87

Price vs S&P 500 (13W)3.29%

Beta0.49x

P/FCF (Annual)36.89x

Revenue / Share (TTM)$1.25

ROE (TTM)12.21%

52-Week Low$1810.00

vGradeF

gGradeA

mGradeB

vgmGradeB

Show chart for

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.29

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$13.89
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

BrainsWay Ltd develops Deep Transcranial Magnetic Stimulation (Deep TMS), a noninvasive neurostimulation platform for treating mental health and neurological disorders. The company currently generates revenue through lease and sale of Deep TMS systems for FDA-approved indications including major depressive disorder, obsessive-compulsive disorder, and smoking addiction. Additional clinical trials are underway to expand the platform's therapeutic applications across psychiatric, neurological, and addiction disorders.